Study of HS-20137 for moderate to severe plaque psoriasis
Part of Skin clinical trials.
This trial tests a new drug called HS-20137 for people with moderate to severe plaque psoriasis. It might help reduce skin symptoms like redness, scaling, and itching.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had plaque psoriasis for at least 6 months and it covers at least 10% of your body or is moderate to severe.
- You have not used certain psoriasis treatments recently, like topical creams, light therapy, or other biologic drugs.
- You are willing to stop current psoriasis treatments and follow the study schedule.
- You do not have other types of psoriasis, serious infections, or autoimmune diseases like lupus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable medicine for people with moderate-to-severe plaque psoriasis. It aims to see if it is safe and effective at reducing symptoms like redness and scaling.
This trial tests a new tablet called SYHX1901 for people with moderate to severe plaque psoriasis. It aims to see if the drug can improve skin symptoms and quality of life over several months.
This trial tests an oral tablet (CMS-D001) for adults with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing psoriasis severity.
This study tests an investigational oral medication called HS-10374 for moderate to severe plaque psoriasis. It aims to see how well it clears skin and prevents flares compared to a placebo, and if it is safe for long-term use.
This trial tests an oral medication called HS-10374 for people with mild to moderate plaque psoriasis who haven't gotten enough relief from topical treatments. The study will check if the drug is safe and effective at clearing psoriasis patches.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
Hear when a new Moderate to Severe Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.